UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2023 | 2022-09-29 | Future report Set alerts | |
| Q4 2022 | 2022-07-12 | 0.01 | 0.01 |
| Q3 2022 | 2022-04-07 | 0.03 | 0.03 |
| Q2 2022 | 2022-01-06 | -0.02 | -0.02 |
| Q1 2022 | 2021-09-30 | -0.02 | -0.02 |
| Q4 2021 | 2021-07-13 | 0.00 | 0.00 |
| Q3 2021 | 2021-03-30 | 0.02 | 0.02 |
| Q2 2021 | 2021-01-07 | 0.01 | 0.01 |
| Q1 2021 | 2020-09-29 | 0.02 | 0.02 |
| Q1 2020 | 2020-09-29 | 0.02 | -0.11 |
| 2016-04-08 | Lower Price Target | KeyBanc | Overweight | $17.00 to $16.00 |
| 2016-04-08 | Initiated Coverage | Piper Jaffray | Neutral | $12.00 |
| 2016-04-08 | Lower Price Target | KeyCorp | Overweight | $17.00 to $16.00 |
| 2016-04-08 | Initiated Coverage | Piper Jaffray Cos. | Neutral | $12.00 |
| 2016-04-05 | Downgrade | Canaccord Genuity | Buy to Hold | $14.50 to $13.00 |
| 2016-01-08 | Reiterated Rating | Canaccord Genuity | Buy | $17.50 to $14.50 |
| 2016-01-08 | Reiterated Rating | Piper Jaffray | Neutral | $14.00 to $12.00 |
| 2015-11-10 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2015-11-10 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
| 2015-10-09 | Reiterated Rating | Piper Jaffray | Hold | $18.00 to $14.00 |
| 2015-10-09 | Lower Price Target | Raymond James | Outperform | $18.00 to $15.00 |
| 2015-10-09 | Reiterated Rating | Canaccord Genuity | Buy | $19.00 to $17.50 |
| 2015-09-23 | Initiated Coverage | Sidoti | Neutral | $14.50 |
| 2015-07-23 | Initiated Coverage | KeyBanc | Overweight | $20.00 |
| 2015-07-18 | Lower Price Target | Raymond James | Outperform | $20.00 to $18.00 |
| 2015-07-17 | Reiterated Rating | Canaccord Genuity | Buy | $19.00 |
| 2015-04-10 | Reiterated Rating | Canaccord Genuity | Buy | $20.00 |
| 2015-01-29 | Reiterated Rating | Canaccord Genuity | Buy | $22.00 |
| 2015-01-11 | Reiterated Rating | Canaccord Genuity | Buy | $22.00 |
| 2015-01-09 | Boost Price Target | Piper Jaffray | Overweight | $17.00 to $21.00 |
| 2014-07-24 | Reiterated Rating | Raymond James | Outperform | $18.00 to $17.00 |
| 2014-06-19 | Upgrade | Canaccord Genuity | Hold to Buy | $16.25 to $20.00 |
| 2014-05-16 | Lower Price Target | Raymond James | $19.00 to $18.00 | |
| 2014-04-10 | Boost Price Target | Canaccord Genuity | $15.50 to $16.25 | |
| 2014-03-12 | Upgrade | Raymond James | Market Perform to Outperform | $19.00 |
| 2013-10-11 | Boost Price Target | Canaccord Genuity | Hold | $11.50 to $13.00 |
| 2012-10-09 | Reiterated | Canaccord Genuity | Hold | $14 to $13.50 |
| 2011-07-15 | Upgrade | Canaccord Genuity | Hold to Buy | $15 to $16.50 |
| 2011-06-14 | Downgrade | Wedbush | Neutral to Underperform | $14 to $12 |
| 2009-09-04 | Reiterated | Caris & Company | Above Average | $13 to $15 |
| 2009-07-17 | Reiterated | Caris & Company | Above Average | $15 to $13 |
| 2009-01-07 | Downgrade | Caris & Company | Buy to Above Average | $20 to $15 |
| 2008-09-26 | Initiated | Caris & Company | Buy | $20 |
| 2008-04-11 | Reiterated | Friedman Billings | Mkt Perform | $14 to $16 |
| 2008-04-03 | Reiterated | Friedman Billings | Mkt Perform | $16 to $14 |
| 2007-09-13 | Reiterated | Canaccord Adams | Buy | $23 to $25 |
| 2007-04-23 | Upgrade | Sun Trust Rbsn Humphrey | Neutral to Buy | $20 |
| 2016-04-08 | Lower Price Target | KeyBanc | Overweight | $17.00 to $16.00 |
| 2016-04-08 | Initiated Coverage | Piper Jaffray | Neutral | $12.00 |
| 2016-04-08 | Lower Price Target | KeyCorp | Overweight | $17.00 to $16.00 |
| 2016-04-08 | Initiated Coverage | Piper Jaffray Cos. | Neutral | $12.00 |
| 2016-04-05 | Downgrade | Canaccord Genuity | Buy to Hold | $14.50 to $13.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ANGO 139 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 6.41M |
| VICTORY CAPITAL MANAGEMENT INC | 2.89M |
| FMR LLC | 2.69M |
| DIMENSIONAL FUND ADVISORS LP | 2.67M |
| Vanguard Group, Inc | 2.59M |
| BlackRock Fund Advisors | 2.51M |
| STATE STREET CORP | 1.51M |
| LOOMIS SAYLES & CO L P | 1.39M |
| BlackRock Institutional Trust Company, N.A. | 0.95M |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.82M |
| NORTHERN TRUST CORP | 0.72M |
| ADAGE CAPITAL PARTNERS GP LLC | 0.70M |
| Numeric Investors LLC | 0.70M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.69M |
| Point72 Asset Management, L.P. | 0.66M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Avista Capital Partners GP, LLC | 1.08% (381406) | ANGO / LNTH / |
| Burgstahler David F | 1.08% (381406) | ANGO / INCR / LNTH / |
| DEVIVO JOSEPH President and CEO | 0.56% (198451) | ANGO / |
| Clemmer James C President and CEO | 0.32% (111817) | ANGO / COV / LNTH / |
| BUCCI VINCENT | 0.25% (88312) | ANGO / |
| Meteny Dennis S | 0.20% (70248) | ANGO / |
| GOLD JEFFREY | 0.17% (61134) | ANGO / |
| DONNELLY HOWARD W | 0.17% (58703) | ANGO / |
| Gould Kevin J | 0.14% (48817) | ANGO / |
| JOHNSON WESLEY | 0.14% (48095) | ANGO / |
| GERSUK D JOSEPH EVP - CFO | 0.13% (47275) | ABMC / ANGO / |
| LaPorte Steve | 0.12% (42177) | ANGO / |
| Frost Mark T EVP and CFO | 0.11% (38389) | ALOG / ANGO / |
| Trowbridge Stephen A SVP and General Counsel | 0.09% (33172) | ANGO / |
| Kapusta Matthew C SVP, Business Development | 0.08% (30062) | ANGO / QURE / |
| PANZER ALAN SVP, GM - Vascular | 0.08% (27500) | ANGO / |
| Bourne George W. IV SVP and CT&OO | 0.07% (23613) | ANGO / |
| SOTO JOHN SVP - Global Franchise Leader | 0.06% (22452) | ANGO / |
| Greiner Charles R VP - Global Franchise | 0.06% (20910) | ANGO / |
| Richard Stark SVP, GM - Oncology | 0.06% (20754) | ANGO / |
| McGill Stephen SVP, GM - International | 0.06% (20715) | ANGO / |
| Greiner Michael EVP and CFO | 0.05% (16193) | ANGO / |
| Campbell Chad Thomas SVP/GM, Vascular Access | 0.04% (15324) | ANGO / |
| Simpson Robert Arthur SVP/GM, Global Vascular | 0.04% (12683) | ANGO / |
| Etlinger Richard Scott SVP - Global Operations | 0.03% (11957) | ANGO / |
| REED JAN STERN | 0.02% (8292) | ANGO / SCL / WBA / |
| Auen Eileen O'Shea | 0.02% (7976) | ANGO / ICFI / |
UM